OTC Trends Report: Cough-cold, switches drive growth
3/10/2015
There was a $1.1 billion gain in OTC sales between 2013 and 2014, according to data culled from IRI, some $500 million of which can be attributed to an increase in sales across all cough-cold/allergy/sinus products and an approximate $300 million to a rise in digestive sales.
In this report, Drug Store News takes a deeper dive into some of the leading trends that are reshaping the OTC category.